Terumo Co. (OTCMKTS:TRUMY) Sees Large Growth in Short Interest

Terumo Co. (OTCMKTS:TRUMY) saw a significant increase in short interest in the month of February. As of February 28th, there was short interest totalling 20,300 shares, an increase of 37.2% from the February 13th total of 14,800 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 308,900 shares, the short-interest ratio is presently 0.1 days.

Terumo Price Performance

Shares of OTCMKTS TRUMY opened at $18.69 on Tuesday. The company has a current ratio of 2.94, a quick ratio of 1.70 and a debt-to-equity ratio of 0.12. The stock has a market cap of $27.67 billion, a P/E ratio of 38.61 and a beta of 0.60. The stock has a 50 day moving average of $18.50 and a two-hundred day moving average of $19.10. Terumo has a twelve month low of $14.06 and a twelve month high of $21.22.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings results on Thursday, February 13th. The company reported $0.16 EPS for the quarter. The business had revenue of $1.73 billion during the quarter.

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.